Algemeen Ziekenhuis Klina

At Algemeen Ziekenhuis Klina, the Cardiologie department is active in studies on cardiovascular diseases, including atherosclerotic cardiovascular disease, hypertension, elevated lipoprotein(a), and established cardiovascular disease. These trials are mainly designed to test new ways to reduce heart attacks, strokes, and other major cardiovascular events, while also improving long-term risk control.

• Reducing major cardiovascular events in people with established vascular disease
• Improving treatment for hypertension and high cardiovascular risk
• Evaluating therapies for lipid-related cardiovascular risk

Overall, this research focuses on prevention, risk reduction, and better outcomes for patients living with chronic heart and vessel conditions.

The site is also strongly involved in neoplasms and hemic and lymphatic diseases, with trials in breast cancer, lung cancer, ovarian cancer, prostate cancer, melanoma, and blood cancers such as multiple myeloma, lymphoma, and myelodysplastic syndromes. The main goal is to assess whether new cancer treatments can improve survival, slow disease progression, and offer better options after standard therapies have stopped working.

• Testing new treatments for advanced and high-risk breast cancer
• Studying therapies for relapsed or refractory blood cancers
• Evaluating options for lung, ovarian, prostate, and skin cancers

These studies reflect a broad oncology program with a focus on more effective and better-tolerated cancer care.

Clinical trials in nutritional and metabolic diseases at Algemeen Ziekenhuis Klina include type 2 diabetes mellitus, obesity, and overweight, often linked with cardiovascular disease and kidney outcomes. These studies aim to determine whether newer treatments can lower cardiovascular risk while also supporting weight management and protecting kidney function.

• Improving outcomes in type 2 diabetes with high cardiovascular risk
• Studying obesity treatments that may also benefit heart and kidney health
• Exploring therapies that address multiple long-term metabolic risks

This area highlights the connection between metabolism, heart health, and chronic disease prevention.

The site contributes to digestive system diseases research through studies in chronic hepatitis B infection, gastroesophageal junction cancer, and colorectal cancer. The purpose of these trials is to improve treatment effectiveness, understand disease control after standard therapy, and support better outcomes in both infectious and cancer-related digestive conditions.

• Evaluating new approaches for chronic hepatitis B
• Testing treatments for advanced gastric and gastroesophageal cancers
• Studying strategies to reduce recurrence in colorectal cancer

These trials show a mix of infectious disease and oncology research within the digestive health field.

Research in female urogenital diseases and pregnancy complications and reproductive and urinary physiological phenomena includes infertility, ovarian cancer, and other reproductive health conditions. One part of this work examines whether fertility procedures can improve the chance of pregnancy and live birth, while other studies focus on more effective treatment options for gynecologic cancers.

• Supporting fertility care and improving pregnancy outcomes
• Testing new treatments for ovarian and fallopian tube cancers
• Exploring better care for women with complex reproductive health needs

This area combines patient-centered fertility research with serious disease-focused gynecologic oncology.

The trial portfolio at Algemeen Ziekenhuis Klina also includes virus diseases and environment and public health topics, such as chronic hepatitis B and studies aimed at preventing complications like cancer-associated thrombosis. The goal is to improve long-term disease control, reduce treatment-related risks, and better understand how broader health factors influence outcomes.

• Studying viral disease management in chronic hepatitis B
• Reducing clotting complications in patients with cancer
• Examining how long-term health risks can be prevented across conditions

These studies extend beyond single diseases and look at prevention and safety across different patient groups.